Class II

Drug Recall: Moxifloxacin 0.8 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for Intraocular Injection, Rx only, Imprimis NJOF, LLC. 1705 Route 46 West, unit 6B, Ledgewood, NJ 07852, NDC 71384-509-08

Imprimis NJOF, LLC · May 14, 2024

Reason for Recall

Lack of Assurance of Sterility

Distribution

Nationwide within the United States

States Affected

NATIONWIDE

Quantity Affected

18,980 vials

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0515-2024

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.